DIRS.INFO The most relevant business & tech news

The Nasdaq boasted its highest closing level since July 31 while the S&P 500 registered its highest close since Aug. 1. Its biggest boost came from Microsoft (MSFT.O) shares which touched a record high and ended up 2%. The benchmark S&P 500 (.SPX) ended less than 1% below its 2023 closing peak reached in late July. Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 27, 2023. The S&P 500 posted 29 new 52-week highs and one new low; the Nasdaq Composite recorded 78 new highs and 90 new lows.

Persons: Bristol Myers, Satya Nadella, Sam Altman, Greg Brockman, Bruce Zaro, Dow, Brendan McDermid, Germany's Bayer, decliners, Sinéad Carew, Amruta, Maju Samuel, Pooja Desai, Richard Chang Organizations: Microsoft, Bristol, Dow, Nasdaq, Nasdaq's, Nvidia, Apple, Granite Wealth Management, Dow Jones, Federal, New York Stock Exchange, REUTERS, Graphics, Traders, Bristol Myers Squibb, Sunday, Boeing, Deutsche Bank, NYSE, Thomson Locations: Providence , Rhode Island, New York City, U.S, Thursday's U.S, New York

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 27, 2023. The S&P 500 information technology sub-index (.SPLRCT), up 1.6%, was the top gainer among the S&P 500's 11 major sectors, getting its biggest boost from Microsoft's shares (MSFT.O) which touched a record high and were last up 2%. Microsoft will also take on Greg Brockman, another OpenAI cofounder, as well as other researchers. The benchmark S&P 500 (.SPX) was also closing back in on its year-to-date high reached in July, just a little over 1% below the milestone. The S&P 500 posted 25 new 52-week highs and one new low; the Nasdaq Composite recorded 70 new highs and 78 new lows.

Persons: Brendan McDermid, Bristol Myers, Satya Nadella, Sam Altman, Greg Brockman, Bruce Zaro, Germany's Bayer, decliners, Sinéad Carew, Amruta, Maju Samuel, Pooja Desai, Richard Chang Organizations: New York Stock Exchange, REUTERS, Microsoft, Bristol, Dow, Nasdaq, Apple, Nvidia, Investors, Granite Wealth Management, Dow Jones, Federal, Traders, Graphics, Bristol Myers Squibb, Sunday, Boeing, Deutsche Bank, NYSE, Thomson Locations: New York City, U.S, Providence , Rhode Island, Thursday's U.S, New York

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 27, 2023. Microsoft's shares (MSFT.O) advanced 2% before the bell after CEO Satya Nadella said Altman is set to join the company to lead a new advanced AI research team. Other megacap stocks were mixed, with Nvidia (NVDA.O) edging 0.6% higher, while Alphabet (GOOGL.O) slipped 0.8%. The benchmark S&P 500 (.SPX) is now only 2% away from its highest level this year reached in July. ET, Dow e-minis were up 18 points, or 0.05%, S&P 500 e-minis were up 3.5 points, or 0.08%, and Nasdaq 100 e-minis were up 28.25 points, or 0.18%.

Persons: Brendan McDermid, Bristol Myers, Sam Altman, Satya Nadella, Altman, Susannah Streeter, Hargreaves Lansdown, Nvidia, Germany's Bayer, Amruta Khandekar, Maju Samuel Organizations: New York Stock Exchange, REUTERS, Microsoft, Bristol, Dow, Nasdaq, Federal Reserve, Nvidia, Fed, Traders, Dow e, Bristol Myers Squibb, Sunday, Thomson Locations: New York City, U.S

☆ Bayer stops blood thinner drug trial due to lack of effect, in major setback
▼ + stars: | 2023-11-20 | by ( Ludwig Burger | ) www.reuters.com time to read: +3 min

Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo Acquire Licensing RightsNov 19 (Reuters) - Germany's Bayer (BAYGn.DE) has aborted a large late-stage trial testing a new anti-clotting drug due to lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. The trial halt, which followed recommendation of independent trial supervisors, marks another setback for a company burdened by a weak herbicide business, high debt and by U.S. lawsuits over the alleged carcinogenic effect of its commonly used Roundup weedkiller. Bayer said it will further analyse the data of the discontinued trial, known as OCEANIC-AF, which was initiated in August 2022. It said the independent trial supervisors recommended the continuation of a separate phase III trial, OCEANIC-STROKE, testing asundexian to prevent repeated strokes in participants who have already suffered one.

Persons: Wolfgang Rattay, Germany's Bayer, Bill Anderson, Bayer, Stefan Oelrich, Johnson, Ludwig Burger, Jose Joseph, Miranda Murray, Christopher Cushing Organizations: Bayer AG, REUTERS, Bristol, Myers Squibb, Johnson, Thomson Locations: Wuppertal, Germany, United States, asundexian, U.S, Frankfurt, Bengaluru

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 27, 2023. Microsoft's shares (MSFT.O) advanced 1.4%, notching a record high after CEO Satya Nadella said Altman is set to join the company to lead a new advanced AI research team. The Fed is expected to issue minutes of its November meeting on Tuesday, which will be parsed for clues on the direction of U.S. interest rates. Advancing issues outnumbered decliners by a 1.03-to-1 ratio on the NYSE and by a 1.39-to-1 ratio on the Nasdaq. The S&P index recorded eight new 52-week highs and one new low, while the Nasdaq recorded 32 new highs and 24 new lows.

Persons: Brendan McDermid, Bristol Myers, Sam Altman, Satya Nadella, Altman, Ken Polcari, Nvidia, Germany's Bayer, Amruta Khandekar, Maju Samuel Organizations: New York Stock Exchange, REUTERS, Microsoft, Bristol, Dow, Nasdaq, Federal Reserve, Kace Capital Advisors, Traders, Dow Jones, Bristol Myers Squibb, Sunday, United Rentals, Ashtead, Boeing, Deutsche Bank, NYSE, Thomson Locations: New York City, U.S

☆ Bayer Cancels Asundexian Phase III Study Program
▼ + stars: | 2023-11-19 | by ( Nov. | At P.M. | ) www.usnews.com time to read: +1 min

(Reuters) - Germany's Bayer AG said on Sunday it is cancelling a phase III study program to investigate the efficacy and safety of asundexian, an oral Factor XIa (FXIa) inhibitor. The decision to stop the study is based on the recommendation by the Independent Data Monitoring Committee (IDMC). IDMC monitoring showed an inferior efficacy of asundexian compared to the control arm of the study. "A phase III study investigating asundexian compared to Apixaban in patients with atrial fibrillation at risk for stroke is being stopped early," the company said in a statement. Bayer, which initiated the study in August 2022, said it will further analyze the data to understand the outcome and will take appropriate measures.

Persons: Bayer, Jose Joseph, Chris Reese Organizations: Reuters, Germany's Bayer AG, Independent Data Monitoring, Bayer Locations: Bengaluru

That's down from 13% of Nike's women's team products which sold out during the same tournament in 2019, the data shows. For that reason, marketers must bear in mind the risk that the growing fanbase could see their support for women's soccer as disingenuous. To recognize the impact grassroots teams have in creating excitement about women's soccer, Adobe's ad also featured London-based community women's soccer clubs Peaches FC and Baesianz FC, said Sabina Strasser, Senior Director, Brand Experience EMEA at Adobe. Sporting goods retailer Fanatics has more than 475 U.S. women's team products for sale this year, up from about 175 in 2019, the company told Reuters. As of Monday, the generic Adidas Women's World Cup soccer ball was among its top sellers in FIFA World Cup Gear.

Persons: Sam Kerr, Carl Recine, Megan Rapinoe, Alex Morgan, Grace Geyoro, Martine Rose, Nike's, Jan Runau, Yvonne Henderson, Bob Dorfman, England's Lionesses, Mary Earps, Bjorn Gulden, Sabina Strasser, Amy Tennery, Sheila Dang, Kate Masters, Shri Navaratnam Organizations: Soccer, Nike FC, REUTERS, Adidas, misstep, U.S, Nike, FIFA, Sporting Goods, Women's, Asisat, United States Women’s, Pricing, In, Pinnacle Advertising, Germany's Bayern Munich women's, Peaches FC, Baesianz FC, Brand, EMEA, Adobe, Sporting, Reuters, U.S ., Thomson Locations: Sydney, Australia, AUCKLAND, New Zealand, DICK's, U.S, French, Barcelona, England, Sweden, Spain, Tuesday's, Germany, London, Auckland, Dallas , Texas, New York

☆ Explainer: After COVID and drug shortages, EU revamps drug laws
▼ + stars: | 2023-04-03 | by ( Maggie Fick | ) www.reuters.com time to read: +5 min

The Commission aims to publish a draft - the biggest overhaul of existing medical laws in two decades - on April 26. A Commission spokesperson said: "The Commission will put forward a balanced and patient-centred proposal, whilst fully supporting an innovative and competitive industry." If the EU health regulator approves a new use for the medicine, they get another year, bringing the total to 11. Fourteen member states have written to the Commission, criticising the idea as costly and harmful for consumers as it could disrupt the generic drugs market. Once the Commission publishes the draft, the European Parliament, Commission and member states will thrash out final details.

☆ Brazil Supreme Court rules Bayer must return $252 mln in GMO soy royalties
▼ + stars: | 2023-02-17 | by ( Ana Mano | ) www.reuters.com time to read: +2 min

The Feb. 13 ruling by Supreme Court Justice Nunes Marques relates to a GMO technology commercially known as Intacta RR2 Pro, created by Monsanto, which was later acquired by Germany's Bayer. Bayer said in a statement it will determine its next steps while noting it would comply with the ruling. The ruling is the latest chapter of a protracted battle opposing the crop science firm and Brazilian farmers, who have launched multiple legal challenges against the firm. Aprosoja-MT said that according to the ruling, Bayer will now have to deposit 1.3 billion reais ($252 million) in an escrow account to return royalties paid by farmers going back to 2018. A lawyer for Aprosoja-MT said Bayer can appeal Marques' ruling at the plenary of the Supreme Court.

☆ Soccer star Son Heung-min gives his top 3 tips for making it as a pro athlete
▼ + stars: | 2023-01-16 | by ( Sophie Kiderlin | ) www.cnbc.com time to read: +1 min

As captain of the South Korean soccer team and a forward for English Premier League club Tottenham Hotspur, Son Heung-min knows a thing or two about becoming a pro athlete. In an interview with CNBC, Son shared his top tips on going pro and handling the pressures that come with it. Son left South Korea at age 16 to join the German soccer club Hamburger SV, with whom he made his first appearance in a top European soccer league in 2010. Son also addressed some of the biggest lessons he has learned from his career so far. "I think the lessons are, just don't try to chase your happiness," he told CNBC.

☆ French farmer awarded 11,000 euros over Bayer pesticide inhalation
▼ + stars: | 2022-12-08 | by ( ) www.reuters.com time to read: +1 min

PARIS, Dec 8 (Reuters) - A French court has ordered Germany's Bayer (BAYGn.DE) to pay compensation of some 11,000 euros ($11,560) to a crop farmer for the accidental inhalation of a weedkiller, ending a 15-year legal battle, his lawyer and the company said on Thursday. "11,000 euros for so much sacrifice," the farmer, Paul Francois, told franceinfo radio. Francois had argued that the fumes he inhaled from the weedkiller Lasso, a product that was subsequently withdrawn from the French market, caused neurological problems, including memory loss, fainting and headaches. Bayer France said in a statement that the sum awarded to the farmer was less than 1% of what he had requested. The exact amount of the damages was 11,135 euros, the farmer's lawyer told Reuters.

FRANKFURT, Oct 14 (Reuters) - Germany's Bayer (BAYGn.DE) said on Friday it plans to legally challenge a jury verdict awarding $275 million to a group of people claiming they suffered from exposure to PCB, a chemical that Bayer's Monsanto business produced until 1977. "We respectfully disagree with the divided jury verdict reached in this 13-plaintiff case and plan to pursue post-trial motions and appeals based on multiple errors and the lack of proof at trial," Germany's Bayer said in a statement. Bayer shares were down 0.9% at 0738 GMT while Germany's blue chip index DAX was up 0.7%. Bayer has since 2020 resolved a majority of cases in litigation with municipalities over waste water contaminated with PCB for $650 million but several other claims remained pending. In August, it set aside 694 million euros for an expected settlement with the State of Oregon over PCB in waste water.

Search resuls for: "Germany's Bayer"

12 mentions found